When the best possible treatment was selected for each subject, the rate of severe hypoglycemia was reduced to 0.7 episodes per patient-year, as opposed to 1.1 for the insulin analog regimen and 1.6 for treatment with human insulins. This evidence concerns the gene INS and Hypoglycemia.